Recall
FDAHealthMarch 13, 2026

ENDO USA, Inc. — Buprenorphine Hydrochloride, Injection, 0.3mg/mL, 5x1 mL Single Dose Vials, Rx only, Manufactured for: Endo USA, Malvern, PA 19855, NDC 42023-179-05.

⚠️ Crystallization; identified as Buprenorphine free base

Is this relevant to me?

Geography
Nationwide
Source agency
FDA
Category
Health
Published
March 13, 2026

USA Nationwide

What's affected?

Product
Buprenorphine Hydrochloride, Injection, 0.3mg/mL, 5x1 mL Single Dose Vials, Rx only, Manufactured for: Endo USA, Malvern, PA 19855, NDC 42023-179-05.
Lot code
84132

Additional details

Lot #: 84132, Exp 02/28/2027; 87693, Exp 03/31/2027

What should I do?

Recommended action

Class II recall. Voluntary: Firm initiated Quantity affected: 34,293 vials.

View original FDA notice →

Get Health recall alerts

Delivered to your inbox. Free. No account required.